Industry Research Reports

Home > Reports > Medical Care > K Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

K Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 125 Pages

Report ld: 2333707

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Killer lymphocytes: referred to as K cells, are differentiated and developed from lymphoid stem cells in the bone marrow. They account for 5% to 7% of the total number of lymphocytes in the blood. They are smaller than T and B lymphocytes and are slightly larger in size. , are medium-sized lymphocytes with a diameter of about 9 to 12 μm. There are lysosomes and secretory granules in the cytoplasm. There are Fc receptors (antibody receptors) on the K cell membrane. When the antibody binds to the target cell (antigen), K cells use Fc receptors to bind to the Fc end of specific antibodies, causing the target cells to quickly lose activity and kill the target cells. K cells must be assisted by antibodies to have immune killing effects, so K cells are also called antibody-dependent Antibody dependent cell-mediated cytotoxic cell (ADCC), K cells mainly attack target cells that are larger than microorganisms, which can be virus-infected cells, such as liver cells in chronic active hepatitis. Due to the large size of these cells, It is difficult to be phagocytized. K cells have an extracellular killing effect. They can clear them and have a clear killing effect on tumor cells. The increase in K cells in the peripheral blood of allogeneic transplant patients shows that K cells are also involved in rejection reactions.

The global market for K Cells was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for K Cells was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for K Cells was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for K Cells was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of K Cells include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for K Cells, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of K Cells by region & country, by Type, and by Application.

The K Cells market size, estimations, and forecasts are provided in terms of sales volume (g) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding K Cells.

Market Segmentation

Report Metric
Details
Report Title
K Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global K Cells Companies Covered
Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services
Global K Cells Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global K Cells Market, Segment by Type
Mogamulizumab

Lorvotuzumab Mertansine

Others
Global K Cells Market, Segment by Application
Cancer

Cardiovascular Diseases

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of K Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of K Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of K Cells in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 K Cells Product Introduction
    1.2 Global K Cells Market Size Forecast
        1.2.1 Global K Cells Sales Value (2019-2030)
        1.2.2 Global K Cells Sales Volume (2019-2030)
        1.2.3 Global K Cells Sales Price (2019-2030)
    1.3 K Cells Market Trends & Drivers
        1.3.1 K Cells Industry Trends
        1.3.2 K Cells Market Drivers & Opportunity
        1.3.3 K Cells Market Challenges
        1.3.4 K Cells Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global K Cells Players Revenue Ranking (2023)
    2.2 Global K Cells Revenue by Company (2019-2024)
    2.3 Global K Cells Players Sales Volume Ranking (2023)
    2.4 Global K Cells Sales Volume by Company Players (2019-2024)
    2.5 Global K Cells Average Price by Company (2019-2024)
    2.6 Key Manufacturers K Cells Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers K Cells Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of K Cells
    2.9 K Cells Market Competitive Analysis
        2.9.1 K Cells Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by K Cells Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in K Cells as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Mogamulizumab
        3.1.2 Lorvotuzumab Mertansine
        3.1.3 Others
    3.2 Global K Cells Sales Value by Type
        3.2.1 Global K Cells Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global K Cells Sales Value, by Type (2019-2030)
        3.2.3 Global K Cells Sales Value, by Type (%) (2019-2030)
    3.3 Global K Cells Sales Volume by Type
        3.3.1 Global K Cells Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global K Cells Sales Volume, by Type (2019-2030)
        3.3.3 Global K Cells Sales Volume, by Type (%) (2019-2030)
    3.4 Global K Cells Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Cancer
        4.1.2 Cardiovascular Diseases
        4.1.3 Others
    4.2 Global K Cells Sales Value by Application
        4.2.1 Global K Cells Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global K Cells Sales Value, by Application (2019-2030)
        4.2.3 Global K Cells Sales Value, by Application (%) (2019-2030)
    4.3 Global K Cells Sales Volume by Application
        4.3.1 Global K Cells Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global K Cells Sales Volume, by Application (2019-2030)
        4.3.3 Global K Cells Sales Volume, by Application (%) (2019-2030)
    4.4 Global K Cells Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global K Cells Sales Value by Region
        5.1.1 Global K Cells Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global K Cells Sales Value by Region (2019-2024)
        5.1.3 Global K Cells Sales Value by Region (2025-2030)
        5.1.4 Global K Cells Sales Value by Region (%), (2019-2030)
    5.2 Global K Cells Sales Volume by Region
        5.2.1 Global K Cells Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global K Cells Sales Volume by Region (2019-2024)
        5.2.3 Global K Cells Sales Volume by Region (2025-2030)
        5.2.4 Global K Cells Sales Volume by Region (%), (2019-2030)
    5.3 Global K Cells Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America K Cells Sales Value, 2019-2030
        5.4.2 North America K Cells Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe K Cells Sales Value, 2019-2030
        5.5.2 Europe K Cells Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific K Cells Sales Value, 2019-2030
        5.6.2 Asia Pacific K Cells Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America K Cells Sales Value, 2019-2030
        5.7.2 South America K Cells Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa K Cells Sales Value, 2019-2030
        5.8.2 Middle East & Africa K Cells Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions K Cells Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions K Cells Sales Value
        6.2.1 Key Countries/Regions K Cells Sales Value, 2019-2030
        6.2.2 Key Countries/Regions K Cells Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States K Cells Sales Value, 2019-2030
        6.3.2 United States K Cells Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States K Cells Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe K Cells Sales Value, 2019-2030
        6.4.2 Europe K Cells Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe K Cells Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China K Cells Sales Value, 2019-2030
        6.5.2 China K Cells Sales Value by Type (%), 2023 VS 2030
        6.5.3 China K Cells Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan K Cells Sales Value, 2019-2030
        6.6.2 Japan K Cells Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan K Cells Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea K Cells Sales Value, 2019-2030
        6.7.2 South Korea K Cells Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea K Cells Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia K Cells Sales Value, 2019-2030
        6.8.2 Southeast Asia K Cells Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia K Cells Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India K Cells Sales Value, 2019-2030
        6.9.2 India K Cells Sales Value by Type (%), 2023 VS 2030
        6.9.3 India K Cells Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Chipscreen Biosciences
        7.1.1 Chipscreen Biosciences Company Information
        7.1.2 Chipscreen Biosciences Introduction and Business Overview
        7.1.3 Chipscreen Biosciences K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Chipscreen Biosciences K Cells Product Offerings
        7.1.5 Chipscreen Biosciences Recent Development
    7.2 Affimed NV
        7.2.1 Affimed NV Company Information
        7.2.2 Affimed NV Introduction and Business Overview
        7.2.3 Affimed NV K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Affimed NV K Cells Product Offerings
        7.2.5 Affimed NV Recent Development
    7.3 Altor BioScience
        7.3.1 Altor BioScience Company Information
        7.3.2 Altor BioScience Introduction and Business Overview
        7.3.3 Altor BioScience K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Altor BioScience K Cells Product Offerings
        7.3.5 Altor BioScience Recent Development
    7.4 Innate Pharma
        7.4.1 Innate Pharma Company Information
        7.4.2 Innate Pharma Introduction and Business Overview
        7.4.3 Innate Pharma K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Innate Pharma K Cells Product Offerings
        7.4.5 Innate Pharma Recent Development
    7.5 Takeda
        7.5.1 Takeda Company Information
        7.5.2 Takeda Introduction and Business Overview
        7.5.3 Takeda K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Takeda K Cells Product Offerings
        7.5.5 Takeda Recent Development
    7.6 Sorrento Therapeutics
        7.6.1 Sorrento Therapeutics Company Information
        7.6.2 Sorrento Therapeutics Introduction and Business Overview
        7.6.3 Sorrento Therapeutics K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Sorrento Therapeutics K Cells Product Offerings
        7.6.5 Sorrento Therapeutics Recent Development
    7.7 NantKwest
        7.7.1 NantKwest Company Information
        7.7.2 NantKwest Introduction and Business Overview
        7.7.3 NantKwest K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 NantKwest K Cells Product Offerings
        7.7.5 NantKwest Recent Development
    7.8 Bristol-Myers Squibb
        7.8.1 Bristol-Myers Squibb Company Information
        7.8.2 Bristol-Myers Squibb Introduction and Business Overview
        7.8.3 Bristol-Myers Squibb K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Bristol-Myers Squibb K Cells Product Offerings
        7.8.5 Bristol-Myers Squibb Recent Development
    7.9 NKT
        7.9.1 NKT Company Information
        7.9.2 NKT Introduction and Business Overview
        7.9.3 NKT K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 NKT K Cells Product Offerings
        7.9.5 NKT Recent Development
    7.10 Henry Ford Health Services
        7.10.1 Henry Ford Health Services Company Information
        7.10.2 Henry Ford Health Services Introduction and Business Overview
        7.10.3 Henry Ford Health Services K Cells Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Henry Ford Health Services K Cells Product Offerings
        7.10.5 Henry Ford Health Services Recent Development

 8 Industry Chain Analysis
    8.1 K Cells Industrial Chain
    8.2 K Cells Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 K Cells Sales Model
        8.5.2 Sales Channel
        8.5.3 K Cells Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer